Most people learn there are eight blood types, the familiar combinations of A, B, AB, and O with positive or negative Rh factor. In reality, the International Society of Blood Transfusion recognizes well over thirty distinct blood group systems, each defined by different antigens on the surface of red blood cells.1Europe PMC / PubMed Central. Blood groups systems Some of these systems are medically urgent in transfusion and pregnancy, others are evolutionary relics that still shape disease risk, and a handful were identified only in the last few years. The eight types you already know are a useful starting point, but they barely scratch the surface.
Why Eight Is a Drastic Undercount
The “eight blood types” shorthand collapses two separate systems into one label. ABO sorts your red cells by whether they carry the A antigen, the B antigen, both, or neither. Rh adds a second layer based on the presence or absence of the D antigen, the most clinically significant of the Rh proteins. Combine the two and you get the familiar eight: A+, A−, B+, B−, AB+, AB−, O+, O−. But ABO and Rh are just the first two chapters of a much longer book.
Each blood group system is defined by one or more antigens, proteins, sugars, or glycolipids embedded in the red cell membrane. The Kell system alone carries more than thirty distinct antigens. The MNS system has close to fifty. When you multiply the number of systems by the number of antigens within each, the combinatorial space becomes enormous. No two people outside of identical twins are likely to match perfectly across every known system, which is why transfusion medicine gets complicated fast once you move beyond routine matching.
Rh-null, the Rarest Blood on Earth
The Rh system itself is far more complex than a simple positive or negative. Beyond the D antigen, there are C, c, E, and e antigens, plus dozens of rarer variants. At the extreme end sits Rh-null, sometimes called “golden blood,” a phenotype in which the red cells carry none of the Rh antigens at all. Fewer than fifty people worldwide have been confirmed as Rh-null.
Having Rh-null makes a person a potential universal donor within the Rh system, because their cells lack every Rh antigen that could trigger a reaction. The catch is that if an Rh-null individual needs blood themselves, only another Rh-null person can safely donate. Compatible blood is almost unobtainable once antibodies develop, so clinicians recommend early autologous storage, banking your own blood in advance, along with extended genotyping to prepare for emergencies.2PubMed. Double heterozygous RhAG mutations causing regulator-type Rhnull phenotype The condition also comes with its own health costs: the absence of Rh proteins weakens the red cell membrane, leading to mild hemolytic anemia, abnormally shaped cells, and increased fragility.3PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran
The Bombay Phenotype and a Missing Precursor
The Bombay phenotype is another blood type that standard testing can miss in dangerous ways. When labs type you for ABO, they are looking for A and B antigens. Both A and B are built on top of a foundation molecule called the H antigen. In the Bombay phenotype, the gene responsible for making that H antigen is inactivated by mutations on both copies of the chromosome.4PubMed. Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals Without H, the body cannot build A or B, so Bombay individuals test as group O. But they are not truly O. They carry antibodies against the H antigen itself, which virtually all O-type blood has in abundance. A standard O-negative transfusion would trigger a severe, potentially fatal reaction.
Bombay phenotype occurs at very low rates globally but is somewhat more common in parts of South Asia, where roughly one in ten thousand people in certain regions carries it. In most Western blood banks, it is vanishingly rare and may go unrecognized unless advanced testing is performed. The practical lesson is stark: a routine ABO test can tell you the wrong story if the underlying biochemistry is unusual.
The Kell System and Pregnancy
After ABO and Rh-D, the Kell system is the blood group with the most severe consequences in clinical medicine. The K antigen, often written as KEL1, is the most potent trigger of immune responses among all non-D blood group antigens.5PubMed Central. Approach to Pregnancy Affected by Kell Alloimmunization In pregnancy, Kell alloimmunization is the second most common cause of severe hemolytic disease of the fetus and newborn, after Rh-D. What makes Kell particularly treacherous is that the antibodies do not just destroy fetal red cells. They also suppress the fetal bone marrow’s ability to produce new ones, a double blow of destruction and suppressed production that can cause profound anemia.6PubMed. Management of pregnancies with anti-K alloantibodies and the predictive value of anti-K titration testing
Kell sensitization usually happens when a Kell-negative woman receives a transfusion containing Kell-positive red cells or becomes pregnant with a Kell-positive fetus. About nine percent of people carry the K antigen, so mismatches are not uncommon. Many blood banks now routinely match for Kell when transfusing women of childbearing age, precisely to prevent this cascade in a future pregnancy.
Duffy, Malaria, and the Limits of Natural Protection
The Duffy blood group system illustrates how blood type antigens can serve double duty. The Duffy antigen acts as a receptor on the red cell surface, and the malaria parasite Plasmodium vivax exploits it to enter the cell. Populations in West and Central Africa have very high rates of the Duffy-negative phenotype, which was long assumed to confer near-complete protection against P. vivax malaria.
That assumption held for decades, but more recent observations have complicated the picture. Multiple cases of P. vivax infection in Duffy-negative Africans have been documented, suggesting the parasite has found alternative entry routes or that the protection was never as absolute as believed.7PubMed Central. Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation? Whether these infections represent a recent evolutionary adaptation by the parasite or were always occurring at low rates and simply missed by surveillance remains an open debate. Either way, the Duffy story is a useful reminder that blood type antigens are not static defense walls; they are part of an ongoing evolutionary arms race between humans and pathogens.
Blood Groups Discovered in the Last Few Years
The catalog of blood group systems is not closed. In 2022, researchers used gene-sequencing tools to pin down the molecular basis of the Er blood group system, identifying mutations in PIEZO1, a gene encoding a mechanosensory ion channel on the red cell surface. The team confirmed five distinct Er antigens, including two never described before, establishing Er as a new formally recognized blood group system.8PubMed Central. Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens
Even more recently, a team from the University of Bristol and NHS Blood and Transplant solved a fifty-year-old puzzle surrounding the AnWj antigen. AnWj was known to exist on red cells but nobody could identify the gene responsible. Whole-exome sequencing revealed that the rare inherited AnWj-negative phenotype is caused by deletions in a gene called MAL, which encodes a membrane protein involved in cell transport and stability. The researchers showed that the Mal protein is present on red cells of AnWj-positive individuals and absent from AnWj-negative ones, and that overexpression of Mal in a cell line was enough to produce the AnWj antigen even without the previously suspected carrier molecule CD44.9PubMed. Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype MAL is now recognized as its own blood group system.10Jurnal Vokasi Kesehatan. The MAL Blood Group System: Discovery, Characteristics, and Clinical Implications Mini Review
These discoveries keep happening because gene-sequencing technology has outpaced the old serological methods. The traditional approach depended on finding a patient who made an unusual antibody and then working backward to identify what antigen provoked it, a slow and serendipitous process. Modern sequencing lets researchers systematically scan genomes of people with unexplained antibody reactions, dramatically shortening the timeline from clinical mystery to recognized blood group.
Why These Systems Matter for Transfusion
For patients who receive blood infrequently, ABO and Rh matching is usually sufficient. The problem intensifies for people who need repeated transfusions, particularly those with sickle cell disease or thalassemia. Each transfusion exposes the recipient to foreign antigens on the donor’s cells, and over time the immune system starts producing antibodies against them. This process, called alloimmunization, makes it progressively harder to find compatible blood.
Standard matching for these patients typically covers the major Rh antigens (C, c, E, e) and the Kell antigen. But antibodies against Duffy, Kidd, MNS, and other systems also arise with significant frequency.11PubMed Central. Red cell transfusion and alloimmunization in sickle cell disease Patients who have already formed one antibody are at higher risk of forming more with future transfusions, creating a snowball effect.12PubMed Central. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia That has pushed researchers and clinicians to advocate for expanded antigen matching well beyond the usual ABO, Rh, and Kell panel, potentially including Kidd, Duffy, MNS, Lewis, Lutheran, and P blood groups as routine screening for chronically transfused patients.13PubMed Central. Erythrocyte Alloimmunization and Transfusion Strategies in Sickle Cell Disease: A Single-Center Analysis
This is also where population-level antigen differences come into play. Different ethnic groups carry different antigen profiles, and when the blood supply is drawn primarily from one demographic while the patients who need the most transfusions belong to another, mismatches pile up. The effect is measurable: alloimmunization rates in sickle cell disease patients, who are predominantly of African descent, are significantly higher than in the general transfusion population, in part because most donor blood comes from individuals of European descent whose antigen profiles differ in predictable ways across Duffy, Rh variants, and other systems.11PubMed Central. Red cell transfusion and alloimmunization in sickle cell disease
Blood Type and Disease Risk
Blood groups are not just labels for transfusion compatibility. The ABO system in particular has well-documented associations with disease risk. People with non-O blood types (A, B, or AB) have a higher incidence of cardiovascular events, including deep vein thrombosis, pulmonary embolism, and heart attack. Large genome-wide association studies have confirmed ABO as a significant locus for thrombosis risk and identified connections to several cardiovascular biomarkers.14PubMed Central. ABO Blood Groups and Cardiovascular Diseases The mechanism appears to be partly tied to clotting factor levels: non-O individuals tend to carry higher concentrations of von Willebrand factor and factor VIII, both of which promote clot formation.15PubMed Central. The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program
These are population-level associations, not destiny. Having type A blood does not mean you will develop heart disease, and having type O does not make you immune. The risk differences are real but modest compared to major modifiable factors like smoking, diet, and exercise. Still, the connections reinforce a broader point: the antigens on your red cells are not inert identification tags. They interact with the immune system, with pathogens, and with clotting pathways in ways that researchers are only beginning to catalog fully.
An Evolutionary Arms Race Written in Sugar and Protein
Why do blood group systems exist in such bewildering variety? The ABO system is shared across many primate species, with the same core genetic variants maintained for at least twenty million years.16PubMed Central. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance That kind of deep conservation usually signals that natural selection is actively maintaining the diversity rather than letting it drift. One leading hypothesis involves pathogens. Many viruses, bacteria, and parasites latch onto specific sugar structures on cell surfaces. If a pathogen evolved to exploit the A antigen for entry, individuals with B or O blood would have an advantage, and vice versa. Over millions of years, this frequency-dependent pressure could keep all three major alleles circulating in a population rather than allowing one to dominate.
Researchers have suggested that the conventional A, B, AB, and O labels may not even capture the full extent of functionally meaningful variation within the ABO system.16PubMed Central. Ancestry runs deeper than blood: the evolutionary history of ABO points to cryptic variation of functional importance There may be cryptic subtypes, genetically distinct variants that routine testing lumps together, each with its own disease associations and selective history. The same evolutionary logic extends beyond ABO: the Duffy-negative phenotype spread through malaria-endemic Africa, certain Rh variants appear at different frequencies in populations with different infectious disease pressures, and many minor blood group antigens likely carry stories we have not yet decoded.
When One Person Carries Two Blood Types
In rare cases, a single individual can carry two distinct blood types simultaneously. This is called chimerism, and it is often first detected when a routine blood typing produces confusing mixed-field results, where some cells react as one type and others as another.17PubMed Central. A dispermic chimera with mixed field blood group B and mosaic 46,XY/47,XYY karyotype Blood group chimerism can arise from twin pregnancies where cells were exchanged between siblings in utero, or from dispermic fertilization events where two sperm fertilize separate parts of the same egg complex. It can also occur artificially after a bone marrow transplant, when the donor’s marrow takes over blood production and the recipient’s blood type gradually shifts to match the donor’s.
Chimeric individuals pose a special challenge for blood banks. Their mixed-field reactions can be mistaken for a rare subtype or a lab error, and getting the right transfusion match requires understanding which cell populations are present and in what proportion. For forensic work and paternity testing, chimerism can be equally confounding, since DNA from blood may not match DNA from other tissues.
Engineering a Way Around the Problem
Given the complexity of blood group matching, some researchers are working to sidestep it entirely. One promising approach uses enzymes to strip the A and B sugar molecules off donated red cells, converting them into something functionally equivalent to type O.18PubMed Central. Toward universal donor blood: Enzymatic conversion of A and B to O type If the process could be made efficient and safe enough for clinical use, it would dramatically expand the usable blood supply by making every ABO type universally compatible. The challenge is ensuring complete antigen removal: even a small residual amount of A or B antigen could trigger an immune reaction in a sensitized recipient.
A parallel effort aims to grow red blood cells in the laboratory from stem cells. A proof-of-concept mini-transfusion of lab-grown cells was performed in a single volunteer as early as 2011, and a larger UK trial has since been planned to test whether manufactured red cells perform as well as donated ones.19PubMed Central. Towards manufactured red blood cells for the treatment of inherited anemia The real appeal of lab-grown blood for the rare-type problem is that you can select your starting cell line. Researchers have estimated that as few as three carefully chosen stem cell lines could produce red cells compatible with over ninety-nine percent of transfusion recipients, and about fifteen lines would cover the full range of rare phenotypes found in a national registry.20PubMed. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges Scaling production to clinical volumes remains the main obstacle, but the technology is moving forward.
Blood Types in Other Species
The complexity of blood grouping is not unique to humans. Dogs have over a dozen recognized blood group antigens, and cats have their own system with clinically important types that can cause fatal neonatal reactions when queen and kitten are mismatched. Horses, cattle, and other domestic species also carry multiple blood group systems, many of which are still being characterized.21PubMed Central. Editorial: Blood Groups in Companion Animals Veterinary transfusion medicine lags behind human practice in part because the antigen diversity in animals is only now being mapped with modern tools. A dog receiving its first transfusion often tolerates a mismatch without visible problems, but a second mismatched transfusion can provoke a severe hemolytic reaction, much the same snowball effect seen in repeatedly transfused human patients. As veterinary emergency care becomes more sophisticated, the demand for proper blood typing in animals is growing rapidly.
Geographic Variation in Antigen Profiles
Blood antigen frequencies vary substantially across populations. Studies of antigen distribution in distinct ethnic groups have found profiles that sit somewhere between those of neighboring continental populations, shaped by geography, historical gene flow, and local selection pressures.22Iraqi Journal of Hematology. Distribution of red cell antigens according to ABO, Rh and other rare blood group systems in Kurdish ethnicity This matters practically because blood banks serve diverse communities. A city hospital drawing from a donor pool that skews heavily toward one ethnic background may struggle to find compatible units for patients from another background, particularly for minor antigens that are not part of standard screening. National rare-blood registries exist in several countries to connect patients who need unusual phenotypes with the scattered donors who carry them, but coverage is uneven and global coordination remains limited.
For individuals who belong to ethnic minorities in a given country, the gap between their antigen profile and the local blood supply can become medically significant over repeated transfusions. This is one of the strongest practical arguments for diversifying donor pools and for moving toward broader antigen matching as a default, not just in special cases.